{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:45:52Z","timestamp":1790894752008,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T00:00:00Z","timestamp":1272067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00428-010-0922-8","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T12:05:45Z","timestamp":1272024345000},"page":"671-679","source":"Crossref","is-referenced-by-count":30,"title":["A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase II\u03b1, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma"],"prefix":"10.1007","volume":"456","author":[{"given":"Helena","family":"Brizova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Kalinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Krskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Mrhalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kodet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,24]]},"reference":[{"key":"922_CR1","first-page":"168","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2001","unstructured":"Swerdlow SH, Berger F, Isaacson PI et al (2001) Mantle cell lymphoma. In: Jaffe ES, Harris NC, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissues, 1st edn. IARC, Lyon, pp 168\u2013170","edition":"1"},{"key":"922_CR2","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","volume":"87","author":"DD Weisenburger","year":"1996","unstructured":"Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma\u2014an entity comes of age. Blood 87:4483\u20134494","journal-title":"Blood"},{"key":"922_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, Lopez-Guillermo A, Campo E et al (1998) Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 82:567\u2013575","journal-title":"Cancer"},{"key":"922_CR4","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES (1999) Mantle-cell lymphoma. Semin Hematol 36:115\u2013127","journal-title":"Semin Hematol"},{"key":"922_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00277-003-0774-2","volume":"83","author":"G Lenz","year":"2004","unstructured":"Lenz G, Dreyling M, Hiddemann W (2004) Mantle cell lymphoma: established therapeutic options and future directions. Ann Hematol 83:71\u201377","journal-title":"Ann Hematol"},{"key":"922_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","volume":"69","author":"R Raty","year":"2002","unstructured":"Raty R, Franssila K, Joensuu H et al (2002) Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 69:11\u201320","journal-title":"Eur J Haematol"},{"key":"922_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W et al (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131:29\u201338","journal-title":"Br J Haematol"},{"key":"922_CR8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","volume":"89","author":"G Ott","year":"1997","unstructured":"Ott G, Kalla J, Ott MM et al (1997) Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421\u20131429","journal-title":"Blood"},{"key":"922_CR9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1080\/10428190410001723331","volume":"45","author":"E Matutes","year":"2004","unstructured":"Matutes E, Parry-Jones N, Brito-Babapulle V et al (2004) The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma 45:2007\u20132015","journal-title":"Leuk Lymphoma"},{"key":"922_CR10","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z et al (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101:4975\u20134981","journal-title":"Blood"},{"key":"922_CR11","first-page":"2253","volume":"95","author":"Y Yatabe","year":"2000","unstructured":"Yatabe Y, Suzuki R, Tobinai K et al (2000) Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 95:2253\u20132261","journal-title":"Blood"},{"key":"922_CR12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.leu.2401470","volume":"13","author":"V Levy","year":"1999","unstructured":"Levy V, Ugo V, Delmer A et al (1999) Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia 13:1343\u20131351","journal-title":"Leukemia"},{"key":"922_CR13","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC et al (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106:4315\u20134321","journal-title":"Blood"},{"key":"922_CR14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1600-0609.2005.00540.x","volume":"75","author":"C Schrader","year":"2005","unstructured":"Schrader C, Janssen D, Meusers P et al (2005) Repp 86: a new prognostic marker in mantle cell lymphoma. Eur J Haematol 75:498\u2013504","journal-title":"Eur J Haematol"},{"key":"922_CR15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.leu.2403387","volume":"18","author":"C Schrader","year":"2004","unstructured":"Schrader C, Meusers P, Brittinger G et al (2004) Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia 18:1200\u20131206","journal-title":"Leukemia"},{"key":"922_CR16","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","volume":"111","author":"O Determann","year":"2008","unstructured":"Determann O, Hoster E, Ott G et al (2008) Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 111:2385\u20132387","journal-title":"Blood"},{"key":"922_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558\u2013565","journal-title":"Blood"},{"key":"922_CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A et al (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185\u2013197","journal-title":"Cancer Cell"},{"key":"922_CR19","first-page":"4213","volume":"51","author":"E Friche","year":"1991","unstructured":"Friche E, Danks MK, Schmidt CA et al (1991) Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res 51:4213\u20134218","journal-title":"Cancer Res"},{"key":"922_CR20","first-page":"58","volume":"49","author":"AM Deffie","year":"1989","unstructured":"Deffie AM, Batra JK, Goldenberg GJ (1989) Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res 49:58\u201362","journal-title":"Cancer Res"},{"key":"922_CR21","doi-asserted-by":"crossref","first-page":"17724","DOI":"10.1016\/S0021-9258(19)77896-X","volume":"263","author":"SM Davies","year":"1988","unstructured":"Davies SM, Robson CN, Davies SL et al (1988) Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 263:17724\u201317729","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"922_CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3190307","volume":"319","author":"T Asano","year":"1996","unstructured":"Asano T, An T, Mayes J et al (1996) Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Biochem J 319(Pt 1):307\u2013313","journal-title":"Biochem J"},{"key":"922_CR23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.leu.2403413","volume":"18","author":"P Korkolopoulou","year":"2004","unstructured":"Korkolopoulou P, Vassilakopoulos TP (2004) Topoisomerase IIalpha as a prognostic factor in mantle cell lymphoma. Leukemia 18:1347\u20131349","journal-title":"Leukemia"},{"key":"922_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00428-003-0809-z","volume":"442","author":"R Kodet","year":"2003","unstructured":"Kodet R, Mrhalova M, Krskova L et al (2003) Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchows Arch 442:538\u2013547","journal-title":"Virchows Arch"},{"key":"922_CR25","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"922_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/PDM.0b013e318146959a","volume":"17","author":"H Brizova","year":"2008","unstructured":"Brizova H, Kalinova M, Krskova L et al (2008) Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders. Diagn Mol Pathol 17:39\u201350","journal-title":"Diagn Mol Pathol"},{"key":"922_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/mcpr.2001.0392","volume":"16","author":"J Lupberger","year":"2002","unstructured":"Lupberger J, Kreuzer KA, Baskaynak G et al (2002) Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes 16:25\u201330","journal-title":"Mol Cell Probes"},{"key":"922_CR28","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710\u20131715","journal-title":"J Immunol"},{"key":"922_CR29","first-page":"209","volume":"2","author":"RD Woessner","year":"1991","unstructured":"Woessner RD, Mattern MR, Mirabelli CK et al (1991) Proliferation- and cell cycle-dependent differences in expression of the 170\u00a0kilodalton and 180\u00a0kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209\u2013214","journal-title":"Cell Growth Differ"},{"key":"922_CR30","first-page":"271","volume":"1","author":"HJ Heidebrecht","year":"2003","unstructured":"Heidebrecht HJ, Adam-Klages S, Szczepanowski M et al (2003) repp 86: a human protein associated in the progression of mitosis. Mol Cancer Res 1:271\u2013279","journal-title":"Mol Cancer Res"},{"key":"922_CR31","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ et al (1997) Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89:2067\u20132078","journal-title":"Blood"},{"key":"922_CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","volume":"2","author":"W Klapper","year":"2009","unstructured":"Klapper W, Hoster E, Determann O et al (2009) Ki-67 as a prognostic marker in mantle cell lymphoma\u2014consensus guidelines of the pathology panel of the European MCL Network. J Hematop 2:103\u2013111","journal-title":"J Hematop"},{"key":"922_CR33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V90.1.226","volume":"90","author":"HJ Heidebrecht","year":"1997","unstructured":"Heidebrecht HJ, Buck F, Steinmann J et al (1997) p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 90:226\u2013233","journal-title":"Blood"},{"key":"922_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311\u2013322","journal-title":"J Cell Physiol"},{"key":"922_CR35","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1200\/JCO.2007.12.0410","volume":"26","author":"E Hartmann","year":"2008","unstructured":"Hartmann E, Fernandez V, Moreno V et al (2008) Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol 26:4966\u20134972","journal-title":"J Clin Oncol"},{"key":"922_CR36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","volume":"22","author":"M Klier","year":"2008","unstructured":"Klier M, Anastasov N, Hermann A et al (2008) Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 22:2097\u20132105","journal-title":"Leukemia"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-0922-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0922-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:57:52Z","timestamp":1711414672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-0922-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,24]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-0922-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,24]]}}}